ghk-cu copper peptides ANAIRUI Serum Cu copper peptides alongside Palmitoyl Tripeptide GHK-Cu Copper Peptide | Eon

Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk

(Use 90 angle if ample fatty tissue

The buyer assumes full responsibility for proper handling and use in accordance with laboratory safety standards

What purity level does this GHK-Cu peptide have

Is GHK-Cu for human or animal use

This peptide has gained attention as a fat-burning peptide with potential benefits for weight management